MEDICENNA THERAPEUTICS, INC

Organization

VANCOUVER, CA

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Interleukin-2 fusion proteins and uses thereof
- Patent number 11,680,090
- Issue date Jun 20, 2023
- Medicenna Therapeutics, Inc.
- Fahar Merchant
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
IL-2 superagonists in combination with anti-PD-1 antibodies
- Patent number 11,542,312
- Issue date Jan 3, 2023
- Medicenna Therapeutics, Inc.
- Fahar Merchant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Interleukin-4 receptor-binding fusion proteins and uses thereof
- Patent number 11,352,402
- Issue date Jun 7, 2022
- MEDICENNA THERAPEUTICS, INC.
- Fahar Merchant
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Interleukin-4 receptor-binding fusion proteins and uses thereof
- Patent number 11,084,856
- Issue date Aug 10, 2021
- Medicenna Therapeutics, Inc.
- Fahar Merchant
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Interleukin-2 fusion proteins and uses thereof
- Patent number 10,781,242
- Issue date Sep 22, 2020
- Medicenna Therapeutics Inc.
- Fahar Merchant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
INTERLEUKIN-2 FUSION PROTEINS AND USES THEREOF
- Publication number 20240067689
- Publication date Feb 29, 2024
- Medicenna Therapeutics, Inc.
- Fahar Merchant
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION THERAPY OF MDNA55 AND A VASCULAR ENDOTHELIAL GROWTH FAC...
- Publication number 20230405115
- Publication date Dec 21, 2023
- Medicenna Therapeutics, Inc.
- Fahar Merchant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIFUNCTIONAL SUPERKINES AND USES THEREOF
- Publication number 20230365642
- Publication date Nov 16, 2023
- Medicenna Therapeutics, Inc.
- Fahar Merchant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-2 SUPERAGONISTS IN COMBINATION WITH ANTI-PD-1 ANTIBODIES
- Publication number 20230080403
- Publication date Mar 16, 2023
- Medicenna Therapeutics, Inc.
- Fahar Merchant
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Interleukin-4 Receptor-Binding Fusion Proteins and Uses Thereof
- Publication number 20220372096
- Publication date Nov 24, 2022
- Medicenna Therapeutics Inc.
- Fahar Merchant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-4R AS A BIOMARKER IN CANCER
- Publication number 20220347268
- Publication date Nov 3, 2022
- Medicenna Therapeutics, Inc.
- Fahar Merchant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERLEUKIN-4 RECEPTOR-BINDING FUSION PROTEINS AND USES THEREOF
- Publication number 20220048965
- Publication date Feb 17, 2022
- Medicenna Therapeutics Inc.
- Fahar Merchant
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INTERLEUKIN-2 FUSION PROTEINS AND USES THEREOF
- Publication number 20210246183
- Publication date Aug 12, 2021
- Medicenna Therapeutics Inc.
- Fahar Merchant
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL-13/IL-4 SUPERKINES: IMMUNE CELL TARGETING CONSTRUCTS AND METHODS...
- Publication number 20210214410
- Publication date Jul 15, 2021
- The Board of Trustees of the Leland Stanford Junior University
- Kenan Christopher Garcia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-4-FUSION FORMULATIONS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM (C...
- Publication number 20200390861
- Publication date Dec 17, 2020
- Medicenna Therapeutics, Inc.
- Fahar Merchant
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL-13 SUPERKINE: IMMUNE CELL TARGETING CONSTRUCTS AND METHODS OF US...
- Publication number 20200095301
- Publication date Mar 26, 2020
- The Board of Trustees of the Leland Stanford Junior University
- Kenan Christopher Garcia
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INTERLEUKIN-4 RECEPTOR-BINDING FUSION PROTEINS AND USES THEREOF
- Publication number 20190100568
- Publication date Apr 4, 2019
- Medicenna Therapeutics Inc.
- Fahar Merchant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERLEUKIN-4 RECEPTOR-BINDING FUSION PROTEINS AND USES THEREOF
- Publication number 20190100567
- Publication date Apr 4, 2019
- Medicenna Therapeutics Inc.
- Fahar Merchant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-2 SUPERAGONISTS IN COMBINATION WITH ANTI-PD-1 ANTIBODIES
- Publication number 20190062395
- Publication date Feb 28, 2019
- Medicenna Therapeutics, Inc.
- Fahar Merchant
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATING CANCER STEM CELLS USING TARGETED CARGO PROTEINS
- Publication number 20160271231
- Publication date Sep 22, 2016
- Medicenna Therapeutics Inc.
- Fahar Merchant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

MEDICENNA THERAPEUTICS, INC

Organization

Patents Grantslast 30 patents

Interleukin-2 fusion proteins and uses thereof

IL-2 superagonists in combination with anti-PD-1 antibodies

Interleukin-4 receptor-binding fusion proteins and uses thereof

Interleukin-4 receptor-binding fusion proteins and uses thereof

Interleukin-2 fusion proteins and uses thereof

Patents Applicationslast 30 patents

INTERLEUKIN-2 FUSION PROTEINS AND USES THEREOF

COMBINATION THERAPY OF MDNA55 AND A VASCULAR ENDOTHELIAL GROWTH FAC...

BIFUNCTIONAL SUPERKINES AND USES THEREOF

IL-2 SUPERAGONISTS IN COMBINATION WITH ANTI-PD-1 ANTIBODIES

Interleukin-4 Receptor-Binding Fusion Proteins and Uses Thereof

IL-4R AS A BIOMARKER IN CANCER

INTERLEUKIN-4 RECEPTOR-BINDING FUSION PROTEINS AND USES THEREOF

INTERLEUKIN-2 FUSION PROTEINS AND USES THEREOF

IL-13/IL-4 SUPERKINES: IMMUNE CELL TARGETING CONSTRUCTS AND METHODS...

IL-4-FUSION FORMULATIONS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM (C...

IL-13 SUPERKINE: IMMUNE CELL TARGETING CONSTRUCTS AND METHODS OF US...

INTERLEUKIN-4 RECEPTOR-BINDING FUSION PROTEINS AND USES THEREOF

INTERLEUKIN-4 RECEPTOR-BINDING FUSION PROTEINS AND USES THEREOF

IL-2 SUPERAGONISTS IN COMBINATION WITH ANTI-PD-1 ANTIBODIES

TREATING CANCER STEM CELLS USING TARGETED CARGO PROTEINS